Drug 1 | |
Generic/Working Name | ETBX‐011 |
Trade Name | None |
Company Name | Etubics (a wholly owned subsidiary of ImmunityBio) |
Drug Type | Vaccine |
Drug Class | Immune therapy |
Dose | 5 × 1011 viral particles per flat dose |
Route | Other; subcutaneous |
Schedule of Administration |
ETBX‐011 = CEA Every 3 weeks for three doses, then every 8 weeks for 1 year |
Drug 2 | |
Generic/Working Name | ETBX‐051 |
Trade Name | None |
Company Name | Etubics (a wholly owned subsidiary of ImmunityBio) |
Drug Type | Vaccine |
Drug Class | Immune therapy |
Dose | 5 × 1011 viral particles per flat dose |
Route | Other; subcutaneous |
Schedule of Administration |
ETBX‐061 = MUC1 Every 3 weeks for three doses, then every 8 weeks for 1 year |
Drug 3 | |
Generic/Working Name | ETBX‐061 |
Trade Name | None |
Company Name | Etubics (a wholly owned subsidiary of ImmunityBio) |
Drug Type | Vaccine |
Drug Class | Immune therapy |
Dose | 5 × 1011 viral particles per flat dose |
Route | Other; subcutaneous |
Schedule of Administration |
ETBX‐051 = brachyury Every 3 weeks for three doses, then every 8 weeks for 1 year |